<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-04-18" modified="2020-08-12" version="153">
<accession>Q8TD08</accession>
<accession>Q2TCF9</accession>
<accession>Q8N362</accession>
<name>MK15_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="23">Mitogen-activated protein kinase 15</fullName>
<shortName>MAP kinase 15</shortName>
<shortName>MAPK 15</shortName>
<ecNumber>2.7.11.24</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Extracellular signal-regulated kinase 7</fullName>
<shortName>ERK-7</shortName>
</alternativeName>
<alternativeName>
<fullName>Extracellular signal-regulated kinase 8</fullName>
<shortName>ERK-8</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="25">MAPK15</name>
<name type="synonym" evidence="4">ERK7</name>
<name type="synonym" evidence="20 22">ERK8</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="16733" last="16743">
<title>ERK8, a new member of the mitogen-activated protein kinase family.</title>
<authorList>
<person name="Abe M.K."/>
<person name="Saelzler M.P."/>
<person name="Espinosa R. III"/>
<person name="Kahle K.T."/>
<person name="Hershenson M.B."/>
<person name="Le Beau M.M."/>
<person name="Rosner M.R."/>
</authorList>
<dbReference type="PubMed" id="11875070"/>
<dbReference type="DOI" id="10.1074/jbc.m112483200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH CSK</scope>
<scope>MUTAGENESIS OF LYS-42; THR-175 AND TYR-177</scope>
<scope>PHOSPHORYLATION AT THR-175 AND TYR-177</scope>
<scope>CHARACTERIZATION</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="10567" last="10576">
<title>Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.</title>
<authorList>
<person name="Iavarone C."/>
<person name="Acunzo M."/>
<person name="Carlomagno F."/>
<person name="Catania A."/>
<person name="Melillo R.M."/>
<person name="Carlomagno S.M."/>
<person name="Santoro M."/>
<person name="Chiariello M."/>
</authorList>
<dbReference type="PubMed" id="16484222"/>
<dbReference type="DOI" id="10.1074/jbc.m513397200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ABL1 AND RET</scope>
<source>
<tissue>Medulla oblongata</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="16821" last="16832">
<title>ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5.</title>
<authorList>
<person name="Saelzler M.P."/>
<person name="Spackman C.C."/>
<person name="Liu Y."/>
<person name="Martinez L.C."/>
<person name="Harris J.P."/>
<person name="Abe M.K."/>
</authorList>
<dbReference type="PubMed" id="16624805"/>
<dbReference type="DOI" id="10.1074/jbc.m512418200"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Biochem. J." volume="394" first="365" last="373">
<title>Characterization of the reversible phosphorylation and activation of ERK8.</title>
<authorList>
<person name="Klevernic I.V."/>
<person name="Stafford M.J."/>
<person name="Morrice N."/>
<person name="Peggie M."/>
<person name="Morton S."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="16336213"/>
<dbReference type="DOI" id="10.1042/bj20051288"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-175 AND TYR-177</scope>
<scope>MUTAGENESIS OF LYS-42; ASP-155; THR-175 AND TYR-177</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="FEBS Lett." volume="583" first="680" last="684">
<title>Regulation of the activity and expression of ERK8 by DNA damage.</title>
<authorList>
<person name="Klevernic I.V."/>
<person name="Martin N.M."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="19166846"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.01.011"/>
</citation>
<scope>PHOSPHORYLATION AT THR-175 AND TYR-177</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-155</scope>
<scope>UBIQUITINATION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="37" last="41">
<title>Ligand interaction scan (LIScan) in the study of ERK8.</title>
<authorList>
<person name="Erster O."/>
<person name="Seger R."/>
<person name="Liscovitch M."/>
</authorList>
<dbReference type="PubMed" id="20638370"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="J. Cell Biol." volume="190" first="575" last="586">
<title>A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA.</title>
<authorList>
<person name="Groehler A.L."/>
<person name="Lannigan D.A."/>
</authorList>
<dbReference type="PubMed" id="20733054"/>
<dbReference type="DOI" id="10.1083/jcb.201002124"/>
</citation>
<scope>INTERACTION WITH PCNA</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLN-300; PRO-390 AND PRO-398</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="EMBO J." volume="30" first="3684" last="3700">
<title>ERK7 is a negative regulator of protein secretion in response to amino-acid starvation by modulating Sec16 membrane association.</title>
<authorList>
<person name="Zacharogianni M."/>
<person name="Kondylis V."/>
<person name="Tang Y."/>
<person name="Farhan H."/>
<person name="Xanthakis D."/>
<person name="Fuchs F."/>
<person name="Boutros M."/>
<person name="Rabouille C."/>
</authorList>
<dbReference type="PubMed" id="21847093"/>
<dbReference type="DOI" id="10.1038/emboj.2011.253"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="8507" last="8522">
<title>Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor alpha (ERRalpha) cellular localization and inhibits its transcriptional activity.</title>
<authorList>
<person name="Rossi M."/>
<person name="Colecchia D."/>
<person name="Iavarone C."/>
<person name="Strambi A."/>
<person name="Piccioni F."/>
<person name="Verrotti di Pianella A."/>
<person name="Chiariello M."/>
</authorList>
<dbReference type="PubMed" id="21190936"/>
<dbReference type="DOI" id="10.1074/jbc.m110.179523"/>
</citation>
<scope>INTERACTION WITH ESRRA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 265-LEU--LEU-269 AND 281-LEU--LEU-285</scope>
<scope>REGION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Autophagy" volume="8" first="1724" last="1740">
<title>MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins.</title>
<authorList>
<person name="Colecchia D."/>
<person name="Strambi A."/>
<person name="Sanzone S."/>
<person name="Iavarone C."/>
<person name="Rossi M."/>
<person name="Dall'Armi C."/>
<person name="Piccioni F."/>
<person name="Verrotti di Pianella A."/>
<person name="Chiariello M."/>
</authorList>
<dbReference type="PubMed" id="22948227"/>
<dbReference type="DOI" id="10.4161/auto.21857"/>
</citation>
<scope>INTERACTION WITH GABARAP; MAP1LC3B AND GABARAPL1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>REGION</scope>
<scope>MUTAGENESIS OF ASP-155 AND 340-TYR--ILE-343</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E01828" last="E01828">
<title>ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration.</title>
<authorList>
<person name="Chia J."/>
<person name="Tham K.M."/>
<person name="Gill D.J."/>
<person name="Bard-Chapeau E.A."/>
<person name="Bard F.A."/>
</authorList>
<dbReference type="PubMed" id="24618899"/>
<dbReference type="DOI" id="10.7554/elife.01828"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-175 AND TYR-177</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-449</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="Oncotarget" volume="7" first="1439" last="1450">
<title>ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism.</title>
<authorList>
<person name="Liwak-Muir U."/>
<person name="Dobson C.C."/>
<person name="Naing T."/>
<person name="Wylie Q."/>
<person name="Chehade L."/>
<person name="Baird S.D."/>
<person name="Chakraborty P.K."/>
<person name="Holcik M."/>
</authorList>
<dbReference type="PubMed" id="26595526"/>
<dbReference type="DOI" id="10.18632/oncotarget.6363"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2017" name="Genetics" volume="207" first="1423" last="1440">
<title>Primary Cilium Formation and Ciliary Protein Trafficking Is Regulated by the Atypical MAP Kinase MAPK15 in Caenorhabditis elegans and Human Cells.</title>
<authorList>
<person name="Kazatskaya A."/>
<person name="Kuhns S."/>
<person name="Lambacher N.J."/>
<person name="Kennedy J.E."/>
<person name="Brear A.G."/>
<person name="McManus G.J."/>
<person name="Sengupta P."/>
<person name="Blacque O.E."/>
</authorList>
<dbReference type="PubMed" id="29021280"/>
<dbReference type="DOI" id="10.1534/genetics.117.300383"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-42</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2017" name="J. Neurosci." volume="37" first="9288" last="9304">
<title>The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.</title>
<authorList>
<person name="Bermingham D.P."/>
<person name="Hardaway J.A."/>
<person name="Refai O."/>
<person name="Marks C.R."/>
<person name="Snider S.L."/>
<person name="Sturgeon S.M."/>
<person name="Spencer W.C."/>
<person name="Colbran R.J."/>
<person name="Miller D.M. III"/>
<person name="Blakely R.D."/>
</authorList>
<dbReference type="PubMed" id="28842414"/>
<dbReference type="DOI" id="10.1523/jneurosci.1582-17.2017"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-42 AND ARG-59</scope>
</reference>
<comment type="function">
<text evidence="3 4 6 8 10 11 12 13 14 15 16 17 18 19">Atypical MAPK protein that regulates several process such as autophagy, ciliogenesis, protein trafficking/secretion and genome integrity, in a kinase activity-dependent manner (PubMed:22948227, PubMed:24618899, PubMed:29021280, PubMed:21847093, PubMed:20733054). Controls both, basal and starvation-induced autophagy throught its interaction with GABARAP, MAP1LC3B and GABARAPL1 leading to autophagosome formation, SQSTM1 degradation and reduced MAP1LC3B inhibitory phosphorylation (PubMed:22948227). Regulates primary cilium formation and the localization of ciliary proteins involved in cilium structure, transport, and signaling (PubMed:29021280). Prevents the relocation of the sugar-adding enzymes from the Golgi to the endoplasmic reticulum, thereby restricting the production of sugar-coated proteins (PubMed:24618899). Upon amino-acid starvation, mediates transitional endoplasmic reticulum site disassembly and inhibition of secretion (PubMed:21847093). Binds to chromatin leading to MAPK15 activation and interaction with PCNA, that which protects genomic integrity by inhibiting MDM2-mediated degradation of PCNA (PubMed:20733054). Regulates DA transporter (DAT) activity and protein expression via activation of RhoA (PubMed:28842414). In response to H(2)O(2) treatment phosphorylates ELAVL1, thus preventing it from binding to the PDCD4 3'UTR and rendering the PDCD4 mRNA accessible to miR-21 and leading to its degradation and loss of protein expression (PubMed:26595526). Also functions in a kinase activity-independent manner as a negative regulator of growth (By similarity). Phosphorylates in vitro FOS and MBP (PubMed:11875070, PubMed:16484222, PubMed:20638370, PubMed:19166846). During oocyte maturation, plays a key role in the microtubule organization and meiotic cell cycle progression in oocytes, fertilized eggs, and early embryos (By similarity). Interacts with ESRRA promoting its re-localization from the nucleus to the cytoplasm and then prevents its transcriptional activity (PubMed:21190936).</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.24"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction>
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.24"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="4 6 7 10">Activated by threonine and tyrosine phosphorylation (PubMed:11875070, PubMed:16336213, PubMed:19166846). Inhibited by dual specificity phosphatases, such as DUSP1 (By similarity). Phosphorylation and activation in response to DNA damaging agents, serum stimulation (PubMed:11875070, PubMed:16336213, PubMed:19166846). Constitutively actived when phosphorylated on Tyr-177. Activity depends on the relative rates of MAPK15 autophosphorylation and dephosphorylation by PTPN1 (PubMed:16336213).</text>
</comment>
<comment type="subunit">
<text evidence="3 4 6 8 9 12 13 15">Interacts with CSK/c-Src, ABL1, RET and TGFB1I1 (PubMed:11875070, PubMed:16484222, PubMed:16624805). Interacts with GABARAP, MAP1LC3B and GABARAPL1; controls, in a kinase-dependent fashion, both basal and starvation-induced autophagy (PubMed:22948227). Interacts with ESRRA; promotes re-localization of ESRRA to the cytoplasm through a XPO1-dependent mechanism then inhibits ESRRA transcriptional activity (PubMed:21190936). Interacts with PCNA; the interaction is chromatin binding- and kinase activity-dependent and prevents MDM2-mediated PCNA destruction by inhibiting the association of PCNA with MDM2 (PubMed:20733054). Interacts with DVL2 (By similarity). Interacts with CLIC3; MAPK15 does not phosphorylates CLIC3 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383794">
<id>Q8TD08</id>
</interactant>
<interactant intactId="EBI-375096">
<id>P24941</id>
<label>CDK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
<location evidence="19">Cytoskeleton</location>
<location evidence="19">Cilium basal body</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cell junction</location>
<location evidence="19">Tight junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
<location evidence="19">Cytoskeleton</location>
<location evidence="19">Microtubule organizing center</location>
<location evidence="19">Centrosome</location>
<location evidence="19">Centriole</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cytoplasmic vesicle</location>
<location evidence="15">Autophagosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11 13">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11 13">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasm</location>
<location evidence="3">Cytoskeleton</location>
<location evidence="3">Spindle</location>
</subcellularLocation>
<text evidence="3 11 13">Co-localizes to the cytoplasm only in presence of ESRRA (PubMed:21190936). Translocates to the nucleus upon activation (PubMed:20638370). At prometaphase I, metaphase I (MI), anaphase I, telophase I, and metaphase II (MII) stages, is stably detected at the spindle (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8TD08-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8TD08-2</id>
<name>2</name>
<name>Erk8 delta</name>
<sequence type="described" ref="VSP_017919 VSP_017920"/>
</isoform>
<isoform>
<id>Q8TD08-3</id>
<name>3</name>
<sequence type="described" ref="VSP_017918 VSP_017921"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6 8">Widely expressed with a maximal expression in lung and kidney.</text>
</comment>
<comment type="domain">
<text evidence="2">The N-terminal region (1-20) is the minimal region necessary for ubiquitination and further proteasomal degradation.</text>
</comment>
<comment type="domain">
<text>The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.</text>
</comment>
<comment type="PTM">
<text evidence="6 7 10">Autophosphorylated on Thr-175 and Tyr-177; activates the enzyme.</text>
</comment>
<comment type="PTM">
<text evidence="4 10">Ubiquitinated (PubMed:19166846). Ubiquitination may allow its tight kinase activity regulation and rapid turnover. May be ubiquitinated by a SCF E3 ligase (By similarity).</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="23">Appears not to be a CSK- and RET-dependent activated kinase.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.11.24"/>
<dbReference type="EMBL" id="AY065978">
<property type="protein sequence ID" value="AAL40897.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY994058">
<property type="protein sequence ID" value="AAY44299.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028034">
<property type="protein sequence ID" value="AAH28034.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6409.2">
<molecule id="Q8TD08-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_620590.2">
<molecule id="Q8TD08-1"/>
<property type="nucleotide sequence ID" value="NM_139021.2"/>
</dbReference>
<dbReference type="SMR" id="Q8TD08"/>
<dbReference type="BioGRID" id="128827">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="IntAct" id="Q8TD08">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000337691"/>
<dbReference type="ChEMBL" id="CHEMBL5198"/>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01017">
<property type="generic name" value="Minocycline"/>
</dbReference>
<dbReference type="DrugCentral" id="Q8TD08"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2090"/>
<dbReference type="iPTMnet" id="Q8TD08"/>
<dbReference type="PhosphoSitePlus" id="Q8TD08"/>
<dbReference type="BioMuta" id="MAPK15"/>
<dbReference type="DMDM" id="74760462"/>
<dbReference type="EPD" id="Q8TD08"/>
<dbReference type="jPOST" id="Q8TD08"/>
<dbReference type="MassIVE" id="Q8TD08"/>
<dbReference type="MaxQB" id="Q8TD08"/>
<dbReference type="PaxDb" id="Q8TD08"/>
<dbReference type="PeptideAtlas" id="Q8TD08"/>
<dbReference type="PRIDE" id="Q8TD08"/>
<dbReference type="ProteomicsDB" id="74209">
<molecule id="Q8TD08-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="74210">
<molecule id="Q8TD08-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="74211">
<molecule id="Q8TD08-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="957">
<property type="antibodies" value="328 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="225689"/>
<dbReference type="Ensembl" id="ENST00000338033">
<molecule id="Q8TD08-1"/>
<property type="protein sequence ID" value="ENSP00000337691"/>
<property type="gene ID" value="ENSG00000181085"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395107">
<molecule id="Q8TD08-3"/>
<property type="protein sequence ID" value="ENSP00000378539"/>
<property type="gene ID" value="ENSG00000181085"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395108">
<molecule id="Q8TD08-2"/>
<property type="protein sequence ID" value="ENSP00000378540"/>
<property type="gene ID" value="ENSG00000181085"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000615253">
<molecule id="Q8TD08-1"/>
<property type="protein sequence ID" value="ENSP00000483093"/>
<property type="gene ID" value="ENSG00000274205"/>
</dbReference>
<dbReference type="GeneID" id="225689"/>
<dbReference type="KEGG" id="hsa:225689"/>
<dbReference type="UCSC" id="uc003yzj.4">
<molecule id="Q8TD08-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="225689"/>
<dbReference type="DisGeNET" id="225689"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000181085.14"/>
<dbReference type="GeneCards" id="MAPK15"/>
<dbReference type="HGNC" id="HGNC:24667">
<property type="gene designation" value="MAPK15"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000181085">
<property type="expression patterns" value="Tissue enhanced (brain, epididymis, fallopian tube)"/>
</dbReference>
<dbReference type="MIM" id="618616">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8TD08"/>
<dbReference type="OpenTargets" id="ENSG00000181085"/>
<dbReference type="PharmGKB" id="PA142671478"/>
<dbReference type="eggNOG" id="KOG0660">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159758"/>
<dbReference type="HOGENOM" id="CLU_000288_181_14_1"/>
<dbReference type="InParanoid" id="Q8TD08"/>
<dbReference type="KO" id="K19603"/>
<dbReference type="OMA" id="KMPQRPR"/>
<dbReference type="OrthoDB" id="741207at2759"/>
<dbReference type="PhylomeDB" id="Q8TD08"/>
<dbReference type="TreeFam" id="TF105101"/>
<dbReference type="PathwayCommons" id="Q8TD08"/>
<dbReference type="SignaLink" id="Q8TD08"/>
<dbReference type="SIGNOR" id="Q8TD08"/>
<dbReference type="BioGRID-ORCS" id="225689">
<property type="hits" value="21 hits in 902 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="MAPK15"/>
<dbReference type="GenomeRNAi" id="225689"/>
<dbReference type="Pharos" id="Q8TD08">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8TD08"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="RNAct" id="Q8TD08">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000181085">
<property type="expression patterns" value="Expressed in right uterine tube and 115 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q8TD08">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005776">
<property type="term" value="C:autophagosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005814">
<property type="term" value="C:centriole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036064">
<property type="term" value="C:ciliary basal body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072687">
<property type="term" value="C:meiotic spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004707">
<property type="term" value="F:MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090494">
<property type="term" value="P:dopamine uptake"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007029">
<property type="term" value="P:endoplasmic reticulum organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030336">
<property type="term" value="P:negative regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905188">
<property type="term" value="P:positive regulation of metaphase/anaphase transition of meiosis I"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905832">
<property type="term" value="P:positive regulation of spindle assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051973">
<property type="term" value="P:positive regulation of telomerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904355">
<property type="term" value="P:positive regulation of telomere capping"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032212">
<property type="term" value="P:positive regulation of telomere maintenance via telomerase"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904491">
<property type="term" value="P:protein localization to ciliary transition zone"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902017">
<property type="term" value="P:regulation of cilium assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003400">
<property type="term" value="P:regulation of COPII vesicle coating"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003527">
<property type="entry name" value="MAP_kinase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01351">
<property type="entry name" value="MAPK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0796">Tight junction</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Mitogen-activated protein kinase 15" id="PRO_0000232637">
<location>
<begin position="1"/>
<end position="544"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="5">
<location>
<begin position="13"/>
<end position="304"/>
</location>
</feature>
<feature type="repeat" description="PXXXP motif" evidence="24">
<location>
<begin position="371"/>
<end position="375"/>
</location>
</feature>
<feature type="repeat" description="PXXXP motif" evidence="24">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="repeat" description="PXXXP motif; regulates binding with chromatin and interaction with PCNA" evidence="24">
<location>
<begin position="386"/>
<end position="390"/>
</location>
</feature>
<feature type="repeat" description="PXXXP motif; regulates binding with chromatin and interaction with PCNA" evidence="24">
<location>
<begin position="394"/>
<end position="398"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="5">
<location>
<begin position="19"/>
<end position="27"/>
</location>
</feature>
<feature type="region of interest" description="Necessary to interact with ESRRA, to regulate its subcellular localization and to inhibit its transcriptional activity" evidence="13">
<location>
<begin position="265"/>
<end position="285"/>
</location>
</feature>
<feature type="region of interest" description="Requires for interaction with GABARAP, MAP1LC3B AND GABARAPL1" evidence="15">
<location>
<begin position="300"/>
<end position="373"/>
</location>
</feature>
<feature type="short sequence motif" description="TXY">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5">
<location>
<position position="137"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="5">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 7 10">
<location>
<position position="175"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6 7 10">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="1">
<location>
<position position="449"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_017918" evidence="21">
<original>M</original>
<variation>MGCPPSPPPPTAVRTLSA</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017919" evidence="22">
<original>DLLALGSGCRASVL</original>
<variation>GAQTACRSGTGAST</variation>
<location>
<begin position="241"/>
<end position="254"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017920" evidence="22">
<location>
<begin position="255"/>
<end position="544"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_017921" evidence="21">
<location>
<begin position="261"/>
<end position="544"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs60732298." id="VAR_061535">
<original>T</original>
<variation>K</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56038219." id="VAR_061536">
<original>S</original>
<variation>P</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not phosphorylated at Thr-175 and Tyr-177." evidence="7">
<original>K</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation and activity. Does not increase dopamine transporter activity. Impairs kinase activity. Does not rescue cilium assembly in MAPK15-depleted cells." evidence="6 18 19">
<original>K</original>
<variation>R</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not increase dopamine transporter activity. Impairs kinase activity." evidence="18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="mutagenesis site" description="Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177." evidence="7 10 15">
<original>D</original>
<variation>A</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with F-177." evidence="6 7 16">
<original>T</original>
<variation>A</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation and activity. Heavily phosphorylated at Thr-175." evidence="6 7">
<original>Y</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with A-175." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly decreases interaction with ESRRA. Impairs interaction with ESRRA; when associated with A-281 and 284-A--A-285. Loses the ability to re-localize ESRRA to the cytoplasm. Does not affect subcellular location in cytoplasm in presence of ESRRA. Loses the ability to repress ESRRA transcriptional activity." evidence="13">
<original>LDALL</original>
<variation>ADAAA</variation>
<location>
<begin position="265"/>
<end position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Markedly decreases interaction with ESRRA. Impairs interaction with ESRRA; when associated with A-265 and 268-A--A-269. Loses the ability to re-localize ESRRA to the cytoplasm. Does not affect subcellular location in cytoplasm in presence of ESRRA.Loses the ability to repress ESRRA transcriptional activity." evidence="13">
<original>LRRLL</original>
<variation>ARRAA</variation>
<location>
<begin position="281"/>
<end position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with PCNA. Associates with chromatin." evidence="12">
<original>Q</original>
<variation>A</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with GABARAP and MAP1LC3B. Affects subcellular localization in autophagosome. Does not induce autophagy." evidence="15">
<original>YQMI</original>
<variation>AQMA</variation>
<location>
<begin position="340"/>
<end position="343"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs chromatin binding; when associated with A-398. Increases kinase activity; when associated with A-398." evidence="12">
<original>P</original>
<variation>A</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs chromatin binding; when associated with A-390. Increases kinase activity; when associated with A-390." evidence="12">
<original>P</original>
<variation>A</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAY44299." ref="2" evidence="23">
<original>H</original>
<variation>R</variation>
<location>
<position position="113"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80Y86"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z2A6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11875070"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16336213"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16484222"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16624805"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19166846"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20638370"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20733054"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21190936"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21847093"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22948227"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24618899"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26595526"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28842414"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29021280"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11875070"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16484222"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20733054"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:24667"/>
</source>
</evidence>
<sequence length="544" mass="59832" checksum="758E0E3B9654AAC5" modified="2002-06-01" version="1">MCTVVDPRIVRRYLLRRQLGQGAYGIVWKAVDRRTGEVVAIKKIFDAFRDKTDAQRTFREITLLQEFGDHPNIISLLDVIRAENDRDIYLVFEFMDTDLNAVIRKGGLLQDVHVRSIFYQLLRATRFLHSGHVVHRDQKPSNVLLDANCTVKLCDFGLARSLGDLPEGPEDQAVTEYVATRWYRAPEVLLSSHRYTLGVDMWSLGCILGEMLRGRPLFPGTSTLHQLELILETIPPPSEEDLLALGSGCRASVLHQLGSRPRQTLDALLPPDTSPEALDLLRRLLVFAPDKRLSATQALQHPYVQRFHCPSDEWAREADVRPRAHEGVQLSVPEYRSRVYQMILECGGSSGTSREKGPEGVSPSQAHLHKPRADPQLPSRTPVQGPRPRPQSSPGHDPAEHESPRAAKNVPRQNSAPLLQTALLGNGERPPGAKEAPPLTLSLVKPSGRGAAPSLTSQAAAQVANQALIRGDWNRGGGVRVASVQQVPPRLPPEARPGRRMFSTSALQGAQGGARALLGGYSQAYGTVCHSALGHLPLLEGHHV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

